These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9579647)

  • 1. Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain.
    Watanabe M; Nonaka R; Hagino Y; Kodama Y
    Neurosci Res; 1998 Feb; 30(2):135-44. PubMed ID: 9579647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
    Hashitani T; Mizukawa K; Kumazaki M; Nishino H
    Neurosci Res; 1998 Jan; 30(1):43-52. PubMed ID: 9572579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of serotonergic nerves in microencephalic rats treated prenatally with methylazoxymethanol.
    Kodama Y; Nonaka R; Hagino Y; Watanabe M
    Neurochem Res; 2000 Apr; 25(4):497-501. PubMed ID: 10823582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.
    Callier S; Morissette M; Grandbois M; Di Paolo T
    Synapse; 2000 Sep; 37(4):245-51. PubMed ID: 10891861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.
    Shimizu K; Matsubara K; Ohtaki K; Fujimaru S; Saito O; Shiono H
    Brain Res; 2003 Jun; 976(2):243-52. PubMed ID: 12763259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased uptake sites for serotonin and dopamine with decreased S2 serotonin receptors in microencephalic rat brain.
    Watanabe M; Kinuya M; Mamiya G; Tatsunuma T; Nagayoshi M; Matsutani T; Tsukada Y
    Neurochem Res; 1990 Oct; 15(10):1017-22. PubMed ID: 2077427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.
    Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR
    J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK
    Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum.
    Collins LM; Meyer JS
    Synapse; 1996 Aug; 23(4):335-43. PubMed ID: 8855519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
    Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
    Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
    Naudon L; Leroux-Nicollet I; Boulay D; Costentin J
    J Neural Transm (Vienna); 2001; 108(4):431-44. PubMed ID: 11475010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
    Huotari M; Passlin M; Nordberg HL; Forsberg M; Kotisaari S; Tuomisto L; Shintani F; Tanaka KF; Reenilä I; Laitinen K; Männistö PT
    J Neurosci Methods; 2001 Aug; 109(1):47-52. PubMed ID: 11489299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional aspects of dopamine metabolism in the putative prefrontal cortex analogue and striatum of pigeons (Columba livia).
    Bast T; Diekamp B; Thiel C; Schwarting RK; Güntürkün O
    J Comp Neurol; 2002 Apr; 446(1):58-67. PubMed ID: 11920720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems.
    Naudon L; Leroux-Nicollet I; Costentin J
    Brain Res; 1992 Oct; 593(1):32-8. PubMed ID: 1360863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
    Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
    Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
    Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
    Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system.
    Bock N; Moll GH; Wicker M; Pilz J; Rüther E; Banaschewski T; Huether G; Rothenberger A
    Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.